Neuromuscular junctions from patients treated with botulinum toxin type-A for blepharospasm after myectomy of their Orbicularis oculi muscle

被引：0
|
作者：
Girard, Brigitte [1 ]
Couesnon, Aurelie [2 ]
Popoff, Michel-Robert [3 ]
Molgo, Jordi [4 ]
机构：
[1] Hop Tenon, Ophthalmol, Paris, France
[2] 2 Inst Neurosci Paris Saclay, Saclay, France
[3] Inst Pasteur, Paris, France
[4] Inst Neurosci Paris Saclay, Gif Sur Yvette, France
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2170
引用
收藏
页数：2
相关论文
共 31 条
  • [21] Botulinum toxin type A affects the transcriptome of cell cultures derived from muscle biopsies of controls and spastic patients
    Zanotti, Simona
    Kapetis, Dimos
    Gibertini, Sara
    Salerno, Franco
    Ciusani, Emilio
    Colombo, Chiara
    Gronchi, Alessandro
    Morandi, Lucia
    Mantegazza, Renato
    Molteni, Franco
    Mora, Marina
    TOXICOLOGY IN VITRO, 2018, 50 : 124 - 136
  • [22] THE TRANSCRIPTOME OF CELL CULTURES DERIVED FROM MUSCLE BIOPSIES OF CONTROLS AND SPASTIC PATIENTS IS AFFECTED BY BOTULINUM TOXIN TYPE A
    Mora, Marina
    Zanotti, Simona
    Kapetis, Dimos
    Gibertini, Sara
    Salerno, Franco
    Ciusani, Emilio
    Morandi, Lucia
    Mantegazza, Renato
    Molteni, Franco
    TOXICON, 2018, 156 : S82 - S82
  • [23] Assessment of changes in masseter muscle by three-dimensional close-range photogrammetry after Botulinum toxin type-A injection: A case report with review of literature
    Bayrak, Nagehan Burcu
    Zeybek, Mustafa
    Sanlioglu, Ismail
    Dolanmaz, Dogan
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2019, 69 (03) : 418 - 422
  • [24] Triceps Surae Muscle Characteristics in Spastic Hemiparetic Stroke Survivors Treated with Botulinum Toxin Type A: Clinical Implications from Ultrasonographic Evaluation
    Battaglia, Marco
    Cosenza, Lucia
    Scotti, Lorenza
    Bertoni, Michele
    Polverelli, Marco
    Loro, Alberto
    Santamato, Andrea
    Baricich, Alessio
    TOXINS, 2021, 13 (12)
  • [25] Submolecular recognition regions of the HN domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients
    Oshima, Minako
    Deitiker, Philip
    Jankovic, Joseph
    Atassi, M. Zouhair
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 300 : 36 - 46
  • [26] Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients
    Oshima, Minako
    Deitiker, Philip
    Jankovic, Joseph
    Aoki, K. Roger
    Atassi, M. Zouhair
    IMMUNOBIOLOGY, 2016, 221 (04) : 568 - 576
  • [27] Improvement in ADL care delivery after treatment with botulinum toxin type A (BOTOX®) in patients with profound ID and spasticity:: Results from a blinded outcomes study
    Gill, Chandler
    Henry, Taylor
    Konrad, Peter
    Charles, David
    TOXICON, 2008, 51 : 27 - 27
  • [28] The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule
    Oshima, Minako
    Deitiker, Philip
    Jankovic, Joseph
    Atassi, M. Zouhair
    IMMUNOLOGICAL INVESTIGATIONS, 2018, 47 (01) : 18 - 39
  • [29] Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial
    Santamato, Andrea
    Micello, Maria Francesca
    Panza, Francesco
    Fortunato, Francesca
    Picelli, Alessandro
    Smania, Nicola
    Logroscino, Giancarlo
    Fiore, Pietro
    Ranieri, Maurizio
    CLINICAL REHABILITATION, 2015, 29 (01) : 50 - 58
  • [30] Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study
    Carlo Colosimo
    David Charles
    Vijay P. Misra
    Pascal Maisonobe
    Savary Om
    Journal of Neurology, 2019, 266 : 3047 - 3047
1234